143 related articles for article (PubMed ID: 30926566)
1. Diverse functions of the thrombopoietin receptor agonist romiplostim rescue individuals exposed to lethal radiation.
Yamaguchi M; Hirouchi T; Yoshioka H; Watanabe J; Kashiwakura I
Free Radic Biol Med; 2019 May; 136():60-75. PubMed ID: 30926566
[TBL] [Abstract][Full Text] [Related]
2. Proteomic changes by radio-mitigative thrombopoietin receptor agonist romiplostim in the blood of mice exposed to lethal total-body irradiation.
Nishida T; Yamaguchi M; Tatara Y; Kashiwakura I
Int J Radiat Biol; 2020 Sep; 96(9):1125-1134. PubMed ID: 32602419
[TBL] [Abstract][Full Text] [Related]
3. The thrombopoietin mimetic romiplostim leads to the complete rescue of mice exposed to lethal ionizing radiation.
Yamaguchi M; Hirouchi T; Yokoyama K; Nishiyama A; Murakami S; Kashiwakura I
Sci Rep; 2018 Jul; 8(1):10659. PubMed ID: 30006622
[TBL] [Abstract][Full Text] [Related]
4. Mitigative Effects of a Combination of Multiple Pharmaceutical Drugs on the Survival of Mice Exposed to Lethal Ionizing Radiation.
Hirouchi T; Ito K; Nakano M; Monzen S; Yoshino H; Chiba M; Hazawa M; Nakano A; Ishikawa J; Yamaguchi M; Tanaka K; Kashiwakura I
Curr Pharm Biotechnol; 2015; 17(2):190-9. PubMed ID: 26306743
[TBL] [Abstract][Full Text] [Related]
5. Mitigative efficacy of the clinical dosage administration of granulocyte colony-stimulating factor and romiplostim in mice with severe acute radiation syndrome.
Yamaguchi M; Suzuki M; Funaba M; Chiba A; Kashiwakura I
Stem Cell Res Ther; 2020 Aug; 11(1):339. PubMed ID: 32746943
[TBL] [Abstract][Full Text] [Related]
6. Romiplostim (Nplate
Bunin DI; Bakke J; Green CE; Javitz HS; Fielden M; Chang PY
Int J Radiat Biol; 2020 Jan; 96(1):145-154. PubMed ID: 31021662
[No Abstract] [Full Text] [Related]
7. Protective Effect of the c-mpl Agonist Romiplostim on Megakaryocytopoiesis of Human CD34
Monzen S; Kimura S; Yamaguchi M; Kashiwakura I
J Interferon Cytokine Res; 2018 May; 38(5):206-212. PubMed ID: 29708814
[TBL] [Abstract][Full Text] [Related]
8. Development of Romiplostim for Treatment of Primary Immune Thrombocytopenia From a Pharmacokinetic and Pharmacodynamic Perspective.
Yang BB; Doshi S; Arkam K; Franklin J; Chow AT
Clin Pharmacokinet; 2016 Sep; 55(9):1045-58. PubMed ID: 27056734
[TBL] [Abstract][Full Text] [Related]
9. COMPREHENSIVE EXPRESSION ANALYSIS OF MIRNAS IN MICE EXPOSED TO LETHAL RADIATION AND/OR RADIO-MITIGATIVE DRUG.
Yamaguchi M; Tsujiguchi T; Kashiwakura I
Radiat Prot Dosimetry; 2019 Oct; 184(3-4):482-485. PubMed ID: 31038713
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics of romiplostim alone and in combination with pegfilgrastim on acute radiation-induced thrombocytopenia and neutropenia in non-human primates.
Wong K; Chang PY; Fielden M; Downey AM; Bunin D; Bakke J; Gahagen J; Iyer L; Doshi S; Wierzbicki W; Authier S
Int J Radiat Biol; 2020 Jan; 96(1):155-166. PubMed ID: 31216213
[No Abstract] [Full Text] [Related]
11. Signaling properties of murine MPL and MPL mutants after stimulation with thrombopoietin and romiplostim.
Rommel MGE; Hoerster K; Milde C; Schenk F; Roser L; Kohlscheen S; Heinz N; Modlich U
Exp Hematol; 2020 May; 85():33-46.e6. PubMed ID: 32417303
[TBL] [Abstract][Full Text] [Related]
12. Romiplostim: a novel thrombopoiesis-stimulating agent.
Perreault S; Burzynski J
Am J Health Syst Pharm; 2009 May; 66(9):817-24. PubMed ID: 19386944
[TBL] [Abstract][Full Text] [Related]
13. The Acute Radiation Syndrome-Mitigator Romiplostim and Secreted Extracellular Vesicles Improved Survival in Mice Acutely Exposed to Myelosuppressive Doses of Ionizing Radiation.
Yamaguchi M; Kashiwakura I
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238707
[TBL] [Abstract][Full Text] [Related]
14. Development of romiplostim: a novel engineered peptibody.
Yang AS
Semin Hematol; 2015 Jan; 52(1):12-5. PubMed ID: 25578414
[TBL] [Abstract][Full Text] [Related]
15. A TPO receptor agonist, ALXN4100TPO, mitigates radiation-induced lethality and stimulates hematopoiesis in CD2F1 mice.
Satyamitra M; Lombardini E; Graves J; Mullaney C; Ney P; Hunter J; Johnson K; Tamburini P; Wang Y; Springhorn JP; Srinivasan V
Radiat Res; 2011 Jun; 175(6):746-58. PubMed ID: 21476857
[TBL] [Abstract][Full Text] [Related]
16. Thrombopoietic agents.
Stasi R; Bosworth J; Rhodes E; Shannon MS; Willis F; Gordon-Smith EC
Blood Rev; 2010; 24(4-5):179-90. PubMed ID: 20493600
[TBL] [Abstract][Full Text] [Related]
17. An Analysis of the Serum Metabolomic Profile for the Radiomitigative Effect of the Thrombopoietin Receptor Agonist Romiplostim in Lethally Whole-Body-Irradiated Mice.
Sato Y; Yamaguchi M; Kashiwakura I
Metabolites; 2022 Feb; 12(2):. PubMed ID: 35208235
[TBL] [Abstract][Full Text] [Related]
18. An update on romiplostim for treatment of acute radiation syndrome.
Singh VK; Seed TM
Drugs Today (Barc); 2022 Mar; 58(3):133-145. PubMed ID: 35274632
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic modeling of romiplostim in animals.
Krzyzanski W; Sutjandra L; Perez-Ruixo JJ; Sloey B; Chow AT; Wang YM
Pharm Res; 2013 Mar; 30(3):655-69. PubMed ID: 23250851
[TBL] [Abstract][Full Text] [Related]
20. Romiplostim in chronic immune thrombocytopenic purpura.
Cersosimo RJ
Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
